...
首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Percutaneous embolization of hemodialysis fistulas by AMPLATZER vascular plug with midterm follow-up.
【24h】

Percutaneous embolization of hemodialysis fistulas by AMPLATZER vascular plug with midterm follow-up.

机译:AMPLATZER血管栓塞经皮介入栓塞治疗血液透析瘘管,并进行中期随访。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To determine the midterm technical and clinical results of endovascular occlusion of native hemodialysis fistulas with the use of the AMPLATZER Vascular Plug (AVP) I and AVP II. MATERIALS AND METHODS: Data from 21 patients who underwent endovascular occlusion of their native fistulas between March 2008 and October 2009 were retrospectively evaluated. The reasons for closing the fistulas were hyperdynamic heart failure (n = 2), venous aneurysm with skin ulceration and nipple formation with impending rupture (n = 5), central venous occlusion that could not be recanalized by an endovascular approach (n = 7), dialysis-associated steal syndrome (n = 2), and critical hand ischemia with a nonhealing ulcer or necrosis (n = 5). RESULTS: All fistulas were embolized successfully by the end of the intervention. No procedure-related complications were observed after the intervention. The follow-up time ranged from 5 months to 24 months, with a mean of 13.5 months. CONCLUSIONS: The results of this study suggest that the AVP is a safe and effective device for the endovascular occlusion of hemodialysis fistulas in selected cases.
机译:目的:使用AMPLATZER血管塞(AVP)I和AVP II,确定天然血液透析瘘管腔内阻塞的中期技术和临床结果。材料与方法:回顾性分析了2008年3月至2009年10月间21例接受天然瘘管血管内闭塞的患者的数据。闭合瘘管的原因有:动力亢进性心力衰竭(n = 2),静脉瘤伴皮肤溃疡和乳头形成伴即将破裂(n = 5),中心静脉闭塞无法通过血管内入路再通(7) ,与透析有关的盗窃综合症(n = 2)和严重的手部缺血伴溃疡不愈或坏死(n = 5)。结果:所有瘘管在手术结束前均成功栓塞。干预后未观察到与手术相关的并发症。随访时间为5个月至24个月,平均13.5个月。结论:本研究结果表明,AVP是在选定病例中用于血管内阻塞性血液透析瘘管的一种安全有效的装置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号